Delivery Order SPE2DB20D3505-SPE2DB21FU4F1

Award Date 9/10/21
Potential Completion Date 9/13/21
Potential Value $1.2K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the supply of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a specialty medication. The $1,144.85 firm-fixed-price delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support military...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the major pharmaceutical distribution company Amerisourcebergen Corporation. The $3,140.48 firm fixed price delivery order is for the supply of the prescription drug Lantus SoloStar 100 unit/mL 3mL. This award is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 held by Amerisourcebergen with the DLA, which serves as the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract, valued at $1,548.48, is for the delivery of Lantus SoloStar 100 unit/mL 3mL, a diabetes medication. This is a firm fixed-price delivery order contract with no set-aside designation, indicating it was awarded through full and open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,469.99, is a Firm Fixed Price Delivery Order for the supply of LANTUS SOLOSTAR 100 UNIT/ML 3ML. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,206.94 firm fixed-price delivery order is for the supply of Lantus SoloStar 100 Unit/mL 3mL, a diabetes medication. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides comprehensive global...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,104.77 firm-fixed-price delivery order is for LANTUS SOLOSTAR 100 UNIT/ML 3ML, a specialty medication. The contract has an ultimate completion date of January 7, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award to Amerisourcebergen Drug Corp (a major pharmaceutical distributor and healthcare solutions provider) was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $9,943.51 firm-fixed-price delivery order is for Lantus SoloSTAR 100 Unit/mL 3mL, a specialty medication used for diabetes management. This award is a call under Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a broad range...
This federal contract award to Amerisourcebergen Drug Corp is a $1,353.60 firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) for the purchase of LANTUS SOLOSTAR 100 UNIT/ML 3ML. The award is associated with a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,816.24 firm fixed-price delivery order covers the supply of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a medical product, with a period of performance through March 2025. This contract is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $3,016.80 firm fixed price delivery order is for the supply of LANTUS SOLOSTAR 100 UNIT/ML 3ML, a specialty pharmaceutical product. This award is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 that serves as the primary...
  • SPE2DB20D3505
    Indefinite Delivery Contract
  • SPE2DB20D3505-SPE2DB21FU4F1
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Lantus SoloStar 100 Unit/mL 3mL medical supplies. The $1,187.20 firm fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen holds with the DLA Troop Support Medical. This IDC serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen's parent company, Cencora, Inc., also holds a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs.

Generated 2/27/25, 10:49 AM